Author · brief 2026-10-18

@Investinc_Intel Investinc_Intel

High-conviction retail growth holder championing a tight basket of unloved AI-leveraged names

Posts concentrated, narrative-driven fundamental bull theses

trader score
+1.69
hit rate
55%
mean α
+1.85%
signals 14d
195

Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY. · Analyst brief as of 2026-10-18.

Their picks, scored

Across their last 20 scored bets: 55% hit rate, +1.85% mean alpha, trader score +1.69. Their last-14d mentions, direction-adjusted, have moved -3.9% since posting (mean over 189 mentions with price data).

Core growth holdings anchor peptide, stablecoin, and infrastructure calls

The author discloses SOFI, HIMS, and ZETA as core holdings and explicitly re-enters IREN. The distinctive bullish calls center on HIMS becoming primarily a peptides business, SOFI's stablecoin traction, and IREN being undervalued. By October 16, the author explicitly compares current HIMS conviction with a prior margin-backed ZETA bet; this is a conviction statement, not evidence of a new leveraged HIMS purchase.

Disclosed book3names the author says they hold — positions, not commentary
LONGHIMS51 sigsLONGZETA43 sigsLONGSOFI41 sigs
Themes5analyst read · 2026-10-18
◆Peptide access and international expansion reshape consumer healthcare
mixedconsistent56 signals
⚠ 91% of theme signals are HIMS — flag pump risk
▲Enterprise AI integration and institutional sponsorship support Zeta
bullfading44 signals
⚠ 98% of theme signals are ZETA — flag pump risk
◆Fintech operating expansion and guidance resilience ahead of earnings
mixedconsistent47 signals
⚠ 87% of theme signals are SOFI — flag pump risk
▲Stablecoin adoption and cross-border payouts expand fintech opportunities
bullconsistent48 signals
⚠ 85% of theme signals are SOFI — flag pump risk
◆Cash-flow infrastructure opportunities versus speculative growth valuation risks
mixedintensifying29 signals
⚠ 41% of theme signals are IREN — flag pump risk
Hypotheses16what the author said, ticker-anchored — ✓ skin = disclosed position behind it
claimtickerdirstrengthsignalsskinthemereceipt
HIMS is an asymmetric, undervalued long-term opportunity, with conviction matching the author's earlier margin-backed ZETA bet.HIMS▲0.803✓Peptide access and international
SoFiUSD is gaining momentum, with its largest reported one-day jump validating the author's adoption thesis.SOFI▲0.422✓Stablecoin adoption and cross-bo
HIMS could become primarily a peptides business and capture most US peptide demand.HIMS▲0.405✓Peptide access and international
IREN has become too cheap and is a buy ahead of technology earnings.IREN▲0.384·Cash-flow infrastructure opportu
ZETA is receiving analyst support through price-target increases and a Goldman upgrade to Buy.ZETA▲0.303✓Enterprise AI integration and in
HIMS is expanding internationally through Australian Hers services, UK hair treatments, and a German dual-platform strategy.HIMS▲0.274✓Peptide access and international
SOFI could benefit from speculative partnerships involving cross-border payments or Visa.SOFI▲0.252✓Stablecoin adoption and cross-bo
DLO offers bullish cross-border-payments exposure, with the Mastercard stablecoin payout launch carrying implications for its opportunity.DLO▲0.212·Stablecoin adoption and cross-bo
FPS's contracted backlog and multiyear AI buildout opportunity remain intact despite tighter utility screening.FPS▲0.203·Cash-flow infrastructure opportu
SOFI's reiterated guidance already contemplated two rate hikes, supporting continued holding despite investor anxiety.SOFI▲0.183✓Fintech operating expansion and
SOFI is a core position to hold through volatility, including the author's intention to retain a losing position throughout the year.SOFI▲0.102✓Fintech operating expansion and
NBIS faces downside following a trendline break, including a possible test of its 200-day moving average.NBIS▼0.102·Cash-flow infrastructure opportu
ONDS has potential but is too early to buy, with dilution and valuation concerns.ONDS▼0.102·Cash-flow infrastructure opportu
ZETA is extending Athena into enterprise-agent ecosystems and pursuing custom AI chips through its NVIDIA collaboration.ZETA▲0.062✓Enterprise AI integration and in
ZETA should benefit from institutional accumulation and bullish options positioning ahead of earnings.ZETA▲0.032✓Enterprise AI integration and in
SOFI is building infrastructure for Mexican financial products, home lending, staking, and crypto-backed lending.SOFI▲0.023✓Fintech operating expansion and
Direction this week

Conviction is concentrated in disclosed core holdings HIMS, SOFI, and ZETA, with an explicit IREN re-entry on October 14 and no disclosed core-position trims or exits. On October 16, the author explicitly equates HIMS conviction with a prior margin-backed ZETA bet, while continuing to defend IREN despite a short-term downside warning on October 15. HIMS and ZETA account for 90.6% and 94.7% of their respective theme signals, flagging promotional concentration risk.

Per-ticker coverage28positions first, then by signal count
tickersignalssentimentcallsposnewsactionalignment
HIMS51+0.41219long call✓ long (has position)
ZETA43+0.44118long call✓ long (has position)
SOFI41+0.33036hold disclosed✓ long (has position)
IREN12+0.47200long callno position bull call
NBIS6+0.14000neutral commentaryneutral
FPS6+0.29002neutral commentaryneutral
GRAL3+0.27001neutral commentaryneutral
NVO3+0.05000neutral commentaryneutral
MA3+0.27000neutral commentaryneutral
DLO2+0.52000bullish commentarycommentary only
ONDS2-0.40000bearish commentarycommentary only
LLY2-0.02000neutral commentaryneutral
JPM2-0.30001bearish commentarycommentary only
AMZN2+0.65000bullish commentarycommentary only
MU1+0.70000bullish commentarycommentary only
V1+0.20000neutral commentaryneutral
PLTR1+0.45000bullish commentarycommentary only
NVDA1+0.70000bullish commentarycommentary only
CRWV1-0.50000bearish commentarycommentary only
NU1+0.35000bullish commentarycommentary only
WFC1+0.00000neutral commentaryneutral
RKLB1-0.60000bearish commentarycommentary only
HOOD1+0.25000neutral commentaryneutral
UAL1+0.25000neutral commentaryneutral
C1+0.00000neutral commentaryneutral
BULL1-0.10000neutral commentaryneutral
MSFT1+0.05000neutral commentaryneutral
F1+0.20000neutral commentaryneutral

Alignment separates skin-in-the-game from commentary: ✓ = the author discloses a position consistent with their talk; “call (no pos)” = directional call without a disclosed position; “commentary” = opinion only.

Conviction trades2explicit CALL_DIRECTIONAL actions, receipts included

hold 1

datetickerwhat they saidreceipt
2026-10-14IRENReiterates IREN as a compelling buy ahead of technology earnings; no additional purchase is specified.

initiate long 1

datetickerwhat they saidreceipt
2026-10-14IRENAnnounces a return to IREN because it has become too cheap.
Position disclosures4skin in the game
ZETA Identifies ZETA as one of three core positions and endorses holding through volatility. held
HIMS Identifies HIMS as one of three core positions and endorses holding through volatility. held
SOFI Identifies SOFI as one of three core positions and endorses holding through volatility. held
SOFI Plans to retain a losing SOFI position throughout the year; no position size is provided. held
News / data points5discrete events + data the author reported
HIMS Reports FDA submission of a pending peptide compounding access policy for White House regulatory review.
HIMS Reports further indications that BPC-157 is included in a White House peptide plan affecting HIMS.
ZETA Reports Goldman upgrading ZETA from Neutral to Buy and raising its target from $30 to $45.
SOFI Reports StoneX initiating SOFI coverage at Buy with a $25 target.
SOFI Reports Goldman cutting SOFI's target from $18 to $15 while maintaining Neutral ahead of earnings.
Best hypotheses5their highest-scoring claims in our index
▲ILMN will join the S&P 500 before September 21 trading, confirming a material index-membership change.
bullHIGH55 co-supporters
▼JPMorgan's adjusted earnings and revenue misses reveal weaker trading and banking execution, undermining expectations of
bearHIGH20 co-supporters
▲Zeta's valuation understates its growth and enterprise-AI opportunity, supporting substantial multiple expansion and hig
bullHIGH20 co-supporters
▲Mastercard and BVNK's Global Money Platform launch provides a concrete new channel combining fiat, stablecoin balances a
bullHIGH13 co-supporters
▲StoneX's Buy initiation introduces a positive sell-side recovery thesis for SOFI, emphasizing improving operations, valu
bullMEDIUM11 co-supporters
Recent signals15receipts included
date (PT)tickerauthorsentwhat they saidsince thenreceipt
2026-10-16IREN@Investinc_Intel+0.45Playfully frames the IREN dip as attractive.-7.7%
2026-10-16SOFI@Investinc_Intel+0.65Reports the largest one-day jump yet for SoFiUSD and treats it as validation of a prior thesis.+0.5%
2026-10-16IREN@Investinc_Intel+0.75Says the author cannot find a credible bearish thesis for IREN.-7.7%
2026-10-16FPS@Investinc_Intel-0.40Morgan Stanley cut FPS's target to $45 from $51 while maintaining Equal Weight.-23.5%
2026-10-16HIMS@Investinc_Intel+0.80Says current conviction in HIMS matches the conviction that previously led to a margin-backed ZETA bet.-1.3%
2026-10-16ZETA@Investinc_Intel+0.40Says current conviction in HIMS matches the conviction that previously led to a margin-backed ZETA bet.+6.8%
2026-10-16HIMS@Investinc_Intel-0.20Reports a HIMS legal officer's sale of 3,461 shares under a preset trading plan.-1.3%
2026-10-16SOFI@Investinc_Intel+0.55Mastercard and BVNK launched a global stablecoin and fiat payout platform with implications for SOFI and DLO.+0.5%
2026-10-16DLO@Investinc_Intel+0.35Mastercard and BVNK launched a global stablecoin and fiat payout platform with implications for SOFI and DLO.+2.7%
2026-10-16MA@Investinc_Intel+0.45Mastercard and BVNK launched a global stablecoin and fiat payout platform with implications for SOFI and DLO.+1.0%
2026-10-16HIMS@Investinc_Intel+0.80Describes a past ZETA bet and presents HIMS as an asymmetric, undervalued long-term opportunity.-1.3%
2026-10-16ZETA@Investinc_Intel+0.40Describes a past ZETA bet and presents HIMS as an asymmetric, undervalued long-term opportunity.+6.8%
2026-10-16HIMS@Investinc_Intel+0.70Enthusiastically endorses HIMS's customer-aligned healthcare model.-1.3%
2026-10-16ZETA@Investinc_Intel+0.40Goldman upgraded ZETA from Neutral to Buy and raised its target from $30 to $45.+6.8%
2026-10-15SOFI@Investinc_Intel+0.60Mocks investors who predicted SOFI would fall to zero, expressing a bullish contrary view.-3.1%

Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.